TipRanks on MSN
MSFT vs. GOOGL vs. NVDA: Which 'strong buy' mega-cap stock has the highest upside potential, according to analysts?
Investors looking for stocks with long-term growth potential can consider mega-cap stocks, which have a market capitalization ...
GOOGL stock is up 32% this year, benefiting from a stock rerating post-regulatory victory on its Chrome browser and strong tailwinds from AI demand. Despite this impressive performance, we believe ...
OpenAI would eat Google’s lunch. ChatGPT was the future of search, and Alphabet (NASDAQ:GOOGL) was a lumbering giant about to ...
15 October 2025, Bavaria, Munich: The Google logo and lettering can be seen on the façade of the company's Munich headquarters building in Munich (Bavaria). The company's development center is located ...
The disruption, which began around 1:50 p.m. ET, sparked tens of thousands of user reports on Downdetector.com. Spotify logged over 46,000 outage reports at its peak; Discord saw nearly 11,000. By ...
Google, and the Alphabet company, have released their latest fiscal results for Q2 2025. The company put up winning metrics in regards to revenue and earnings-per-share (EPS), delivering well on ...
Tech giant Google (GOOGL) is set to report its Q3 earnings results on October 29 after the market closes. Analysts are expecting earnings per share to come in at $2.27 on revenue of $99.95 billion.
Wall Street remains sharply divided on Alphabet Inc‘s (NASDAQ:GOOGL) AI future. What Happened: At a Bank of America Securities-hosted debate attended by over 200 investors, bulls praised Google's data ...
Alphabet offers investors exposure to powerful tech megatrends like artificial intelligence (AI), cybersecurity, and autonomous transportation -- all under one roof. Alphabet trades under two ticker ...
Google (NASDAQ:GOOG) (NASDAQ:GOOGL) said on Thursday that its AI Mode on its ubiquitous search engine will now be available around the globe, coming to 180 different countries and territories. The AI ...
The Alphabet Analyst: Analyst Doug Anmuth reiterated an Overweight rating and price target of $232. The Alphabet Thesis: While the financial implications of the remedy are "difficult to predict," it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results